Poxvirus Cell Entry: How Many Proteins Does it Take?

Knipe, 2007, Poxviridae: The Viruses and Their Replication, Fields Virology, 2, 2905

Upton, 2003, Poxvirus orthologous clusters: Toward defining the minimum essential poxvirus genome, J. Virol., 77, 7590, 10.1128/JVI.77.13.7590-7600.2003

Moss, 2006, Poxvirus entry and membrane fusion, Virology, 344, 48, 10.1016/j.virol.2005.09.037

DePamphilis, M.L. (2006). DNA Replication & Human Disease, Cold Spring Harbor Laboratory Press.

Yang, 2011, Expression profiling of the intermediate and late stages of poxvirus replication, J. Virol., 85, 9899, 10.1128/JVI.05446-11

Condit, 2006, In a nutshell: Structure and assembly of the vaccinia virion, Adv. Virus Res., 66, 31, 10.1016/S0065-3527(06)66002-8

Hollinshead, 1999, Vaccinia virus intracellular mature virions contain only one lipid membrane, J. Virol., 73, 1503, 10.1128/JVI.73.2.1503-1517.1999

Heuser, 2005, Deep-etch EM reveals that the early poxvirus envelope is a single membrane bilayer stabilized by a geodetic “Honeycomb” Surface coat, J. Cell Biol., 169, 269, 10.1083/jcb.200412169

Cyrklaff, 2005, Cryo-electron tomography of vaccinia virus, Proc. Natl. Acad. Sci. USA, 102, 2772, 10.1073/pnas.0409825102

Hiller, 1985, Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment, J. Virol., 55, 651, 10.1128/jvi.55.3.651-659.1985

Schmelz, 1994, Assembly of vaccinia virus: The second wrapping cisterna is derived from the trans Golgi network, J. Virol., 68, 130, 10.1128/jvi.68.1.130-147.1994

Tooze, 1993, Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes, Eur. J. Cell Biol., 60, 163

Ward, 2001, Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails, J. Virol., 75, 11651, 10.1128/JVI.75.23.11651-11663.2001

Smith, 2002, The formation and function of extracellular enveloped vaccinia virus, J. Gen. Virol., 83, 2915, 10.1099/0022-1317-83-12-2915

Blasco, 1992, Role of cell-associated enveloped vaccinia virus in cell-to-cell spread, J. Virol., 66, 4170, 10.1128/jvi.66.7.4170-4179.1992

Roper, 1998, The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to- cell spread of vaccinia virus, J. Virol., 72, 4192, 10.1128/JVI.72.5.4192-4204.1998

Sanderson, 1998, Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion, J. Gen. Virol., 79, 1415, 10.1099/0022-1317-79-6-1415

Wolffe, 1997, The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus, J. Virol., 71, 3904, 10.1128/jvi.71.5.3904-3915.1997

Wolffe, 1998, Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread, Virology, 244, 20, 10.1006/viro.1998.9103

Payne, 1980, Significance of extracellular virus in the in vitro and in vivo dissemination of vaccinia virus, J. Gen. Virol., 50, 89, 10.1099/0022-1317-50-1-89

Blasco, 1993, Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: Effect of a point mutation in the lectin homology domain of the A34R gene, J. Virol., 67, 3319, 10.1128/jvi.67.6.3319-3325.1993

Katz, 2003, Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-dontaining microvilli without preventing tyrosine phosphorylation of the A36R protein, J. Virol., 77, 12266, 10.1128/JVI.77.22.12266-12275.2003

White, 2008, Structures and mechanisms of viral membrane fusion proteins: Multiple variations on a common theme, Crit. Rev. Biochem. Mol. Biol., 43, 189, 10.1080/10409230802058320

Armstrong, 1973, The mode of entry of vaccinia virus into L cells, J. Gen. Virol., 21, 533, 10.1099/0022-1317-21-3-533

Carter, 2005, Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans, J. Gen. Virol., 86, 1279, 10.1099/vir.0.80831-0

Townsley, 2006, Vaccinia virus entry into cells via a low pH-dependent-endosomal pathway, J. Virol., 80, 8899, 10.1128/JVI.01053-06

Law, 2006, Ligand-induced and non-fusogenic dissolution of a viral membrane, Proc. Natl. Acad. Sci. USA, 103, 5989, 10.1073/pnas.0601025103

Dales, 1961, The development of vaccinia virus in earle's L strain cells as examined by electron microscopy, J. Biophys. Biochem. Cytol., 10, 475, 10.1083/jcb.10.4.475

Dales, 1964, The cycle of multiplication of vaccinia virus in earle’s strain L cells. I. Uptake and penetration, Virology, 24, 278, 10.1016/0042-6822(64)90167-9

Townsley, 2007, Two distinct low-pH steps promote entry of vaccinia virus, J. Virol., 81, 8613, 10.1128/JVI.00606-07

Bengali, 2009, Vaccinia virus strain differences in cell attachment and entry, Virology, 389, 132, 10.1016/j.virol.2009.04.012

Villa, 2010, Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells, Virology, 401, 266, 10.1016/j.virol.2010.02.027

Chang, 2010, Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into hela, CHO-K1, and L cells, J. Virol., 84, 8422, 10.1128/JVI.00599-10

Whitbeck, 2009, Vaccinia virus exhibits cell-type-dependent entry characteristics, Virology, 385, 383, 10.1016/j.virol.2008.12.029

Li, 1998, The non-permissive infection of insect (gypsy moth) LD-652 cells by vaccinia virus, Virology, 248, 74, 10.1006/viro.1998.9241

Moser, 2010, A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics, PLoS Pathog., 6, e1000954, 10.1371/journal.ppat.1000954

Bengali, 2011, Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcription, PLoS One, 6, e17248, 10.1371/journal.pone.0017248

Mercer, 2008, Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells, Science, 320, 531, 10.1126/science.1155164

Huang, 2008, A novel cellular protein, VPEF, facilitates vaccinia virus penetration into hela cells through fluid phase endocytosis, J. Virol., 82, 7988, 10.1128/JVI.00894-08

Mercer, 2010, Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry, Proc. Natl. Acad. Sci. USA, 107, 9346, 10.1073/pnas.1004618107

Marsh, 1987, Vaccinia virus and the EGF receptor: A portal of entry for infectivity?, J. Cell. Biochem., 34, 239, 10.1002/jcb.240340403

Eppstein, 1985, Epidermal growth factor receptor occupancy inhbits vaccinia virus infection, Nature (London), 318, 550, 10.1038/318663a0

Lalani, 1999, Use of chemokine receptors by poxviruses, Science, 286, 1968, 10.1126/science.286.5446.1968

Schroeder, N., Chung, C.S., Chen, C.H., Liao, C.L., and Chang, W. (2012). The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis. J. Virol.

Sandgren, 2010, A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells, PLoS Pathog., 6, e1000866, 10.1371/journal.ppat.1000866

Schmidt, 2011, Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture, EMBO J., 30, 3647, 10.1038/emboj.2011.245

Ichihashi, 1983, The activation of vaccinia virus infectivity by the transfer of phosphatidylserine from the plasma membrane, Virology, 130, 306, 10.1016/0042-6822(83)90085-5

Oie, 1985, Reversible inactivation and reactivation of vaccinia virus by manipulation of viral lipid composition, Virology, 142, 299, 10.1016/0042-6822(85)90338-1

Laliberte, 2009, Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry, Proc. Natl. Acad. Sci. USA, 106, 17517, 10.1073/pnas.0909376106

Morizono, 2011, The soluble serum protein gGas6 bridges virion envelope phosphatidylserine to the tam receptor tyrosine kinase axl to mediate viral entry, Cell Host Microbe, 9, 286, 10.1016/j.chom.2011.03.012

Vanderplasschen, 1997, A novel virus binding assay using confocal microscopy: Demonstration that intracellular and extracellular vaccinia virions bind to different cellular receptors, J. Virol., 71, 4032, 10.1128/jvi.71.5.4032-4041.1997

Chahroudi, 2005, Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor, J. Virol., 79, 10397, 10.1128/JVI.79.16.10397-10407.2005

Hsiao, 1999, Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells, J. Virol., 73, 8750, 10.1128/JVI.73.10.8750-8761.1999

Chung, 1998, A27L protein mediates vaccinia virus interaction with cell surface heparin sulfate, J. Virol., 72, 1577, 10.1128/JVI.72.2.1577-1585.1998

Hsiao, 1998, Cell surface proteoglycans are necessary for A27L protein- mediated cell fusion: Identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain, J. Virol., 72, 8374, 10.1128/JVI.72.10.8374-8379.1998

Lin, 2000, Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo, J. Virol., 74, 3353, 10.1128/JVI.74.7.3353-3365.2000

Vazquez, 1999, Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus, J. Virol., 73, 9098, 10.1128/JVI.73.11.9098-9109.1999

Chiu, 2007, Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin, J. Virol., 81, 2149, 10.1128/JVI.02302-06

Rodriguez, 1993, The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene, J. Virol., 67, 3435, 10.1128/jvi.67.6.3435-3440.1993

Howard, 2008, Vaccinia virus A26 and A27 proteins form a stable complex tethered to mature virions by association with the A17 transmembrane protein, J. Virol., 82, 12384, 10.1128/JVI.01524-08

Ching, 2009, Disulfide bond formation at the C termini of vaccinia virus A26 andA27 proteins does not require viral redox enzymes and suppresses glycosaminoglycan-mediated cell fusion, J. Virol., 83, 6464, 10.1128/JVI.02295-08

Wolffe, 2000, Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication, J. Virol., 74, 7518, 10.1128/JVI.74.16.7518-7528.2000

Ward, 2005, Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions, J. Virol., 79, 4755, 10.1128/JVI.79.8.4755-4763.2005

McKelvey, 2002, Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusions, J. Virol., 76, 11216, 10.1128/JVI.76.22.11216-11225.2002

Patel, 1986, Isolation of cowpox virus A-type inclusions and characterization of their major protein component, Virology, 149, 174, 10.1016/0042-6822(86)90119-4

Amegadzie, 1992, Frame-shift mutations within the vaccinia virus A-type inclusion protein gene, Virology, 186, 777, 10.1016/0042-6822(92)90046-R

Foo, 2009, Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans, Virology, 385, 368, 10.1016/j.virol.2008.12.019

Satheshkumar, 2012, Sequence-divergent chordopoxvirus homologs of the O3 protein maintain functional interactions with components of the vaccinia virus entry-fusion complex, J. Virol., 86, 1696, 10.1128/JVI.06069-11

Senkevich, 2004, Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene, J. Virol., 78, 2357, 10.1128/JVI.78.5.2357-2366.2004

Townsley, 2005, Vaccinia virus A21 virion membrane protein is required for cell entry and fusion, J. Virol., 79, 9458, 10.1128/JVI.79.15.9458-9469.2005

Townsley, 2005, The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is requried for cell entry and cell-cell fusion, J. Virol., 79, 10988, 10.1128/JVI.79.17.10988-10998.2005

Senkevich, 2005, Poxvirus multiprotein entry-fusion complex, Proc. Natl. Acad. Sci. USA, 102, 18572, 10.1073/pnas.0509239102

Ojeda, 2006, Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene, J. Virol., 80, 51, 10.1128/JVI.80.1.51-61.2006

Senkevich, 2004, Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway, J. Virol., 78, 2348, 10.1128/JVI.78.5.2348-2356.2004

Turner, 2007, Vaccinia virus temperature-sensitive mutants in the A28 gene produce non-infectious virions that bind to cells but are defective in entry, Virology, 366, 62, 10.1016/j.virol.2007.03.060

Izmailyan, 2006, The envelope G3L protein is essential for entry of vaccinia virus into host cells, J. Virol., 80, 8402, 10.1128/JVI.00624-06

Ojeda, 2006, Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex, J. Virol., 80, 9822, 10.1128/JVI.00987-06

Senkevich, 2005, Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion, J. Virol., 79, 4744, 10.1128/JVI.79.8.4744-4754.2005

Nelson, 2008, A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity, J. Virol., 82, 6244, 10.1128/JVI.00434-08

Wolfe, 2012, Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex, J. Virol., 86, 293, 10.1128/JVI.05935-11

Satheshkumar, 2009, Characterization of a newly identified 35 amino acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses, J. Virol., 83, 12822, 10.1128/JVI.01744-09

Brown, 2006, Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein, J. Virol., 80, 9455, 10.1128/JVI.01149-06

Bisht, 2008, Vaccinia virus L1 protein is required for cell entry and membrane fusion, J. Virol., 82, 8687, 10.1128/JVI.00852-08

Nichols, 2008, The vaccinia I2L gene encodes a membrane protein with an essential role in virion entry, J. Virol., 82, 10247, 10.1128/JVI.01035-08

Kochan, 2008, Membrane cell fusion activity of the vaccinia virus A17-A27 protein complex, Cell. Microbiol., 10, 1149

Esteban, 1995, Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis, J. Virol., 69, 4640, 10.1128/jvi.69.8.4640-4648.1995

Wolffe, 1996, Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis, J. Virol., 70, 2797, 10.1128/jvi.70.5.2797-2808.1996

Wagenaar, 2008, Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex, J. Virol., 82, 5153, 10.1128/JVI.00162-08

Wolfe, 2011, Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex, Virology, 412, 278, 10.1016/j.virol.2011.01.014

Senkevich, 2002, Complete pathway for protein disulfide bond formation encoded by poxviruses, Proc. Natl. Acad. Sci. USA, 99, 6667, 10.1073/pnas.062163799

Ryser, 1994, Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction, Proc. Natl. Acad. Sci. USA, 91, 4559, 10.1073/pnas.91.10.4559

Markovic, 2004, Thiol/disulfide exchange is a pre-requisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry, Blood, 103, 1586, 10.1182/blood-2003-05-1390

Wallin, 2005, The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization, J. Virol., 79, 1678, 10.1128/JVI.79.3.1678-1685.2005

Jain, 2007, Thiol/disulfide exchange is required for membrane fusion directed by the newcastle disease virus fusion protein, J. Virol., 81, 2328, 10.1128/JVI.01940-06

Nelson, 2008, Vaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodies, Virology, 380, 394, 10.1016/j.virol.2008.08.009

Shinoda, 2010, The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein, Virology, 405, 41, 10.1016/j.virol.2010.05.025

Wolffe, 1995, A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies, Virology, 211, 53, 10.1006/viro.1995.1378

Ichihashi, 1996, Neutralizing epitopes on penetration protein of vaccinia virus, Virology, 220, 491, 10.1006/viro.1996.0337

Franke, 1990, Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25, J. Virol., 64, 5988, 10.1128/jvi.64.12.5988-5996.1990

Ravanello, 1994, Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope, J. Gen. Virol., 75, 1479, 10.1099/0022-1317-75-6-1479

Whitbeck, 2005, Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene, Virology, 341, 59, 10.1016/j.virol.2005.07.006

Ravanello, 1994, Conditional lethal expression of the vaccinia virus L1R myristylated protein reveals a role in virus assembly, J. Virol., 68, 6401, 10.1128/jvi.68.10.6401-6410.1994

Bisht, 2010, Kinetics and intracellular location of intramolecular disulfide bond formation mediated by the cytoplasmic redox system encoded by vaccinia virus, Virology, 398, 187, 10.1016/j.virol.2009.11.026

Foo, C.H., Whitbeck, J.C., Ponce de Leon, M., Saw, W.T., Cohen, G.H., and Eisenberg, R.J. (2012). The myristate moiety and amino-terminus of the vaccinia virus L1 constitute a bipartite functional region needed for entry. J. Virol.

Su, 2005, The 1.51-Å structure of the poxvirus L1 protein, a target of potent neutralizing antibodies, Proc. Natl. Acad. Sci. USA, 102, 4240, 10.1073/pnas.0501103102

Su, 2007, Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein, Virology, 368, 331, 10.1016/j.virol.2007.06.042

Doms, 1990, Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane, J. Virol., 64, 4884, 10.1128/jvi.64.10.4884-4892.1990

Laliberte, 2011, The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components, PLoS Pathog., 7, e1002446, 10.1371/journal.ppat.1002446

Locker, 2000, Entry of the two infectious forms of vaccinia virus at the plasma membrane is signaling-dependent for the IMV but not the EEV, Mol. Biol. Cell, 11, 2497, 10.1091/mbc.11.7.2497

Zheng, 1991, Reorganization of cytoplasmic structures during cell fusion, J. Cell Sci., 100, 431, 10.1242/jcs.100.3.431

Eitzen, 2003, Actin remodeling to facilitate membrane fusion, Biochim. Biophys. Acta, 1641, 175, 10.1016/S0167-4889(03)00087-9

Massarwa, 2007, WIP/WASp-based actin-polymerization machinery is essential for myoblast fusion in Drosophila, Dev. Cell, 12, 557, 10.1016/j.devcel.2007.01.016

Kallewaard, 2005, Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus, Virology, 331, 73, 10.1016/j.virol.2004.10.010

Gower, 2005, RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology, J. Virol., 79, 5326, 10.1128/JVI.79.9.5326-5336.2005

Pontow, 2004, Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion, J. Virol., 78, 7138, 10.1128/JVI.78.13.7138-7147.2004

Schowalter, 2006, Rho GTPase activity modulates paramyxovirus fusion protein-mediated cell-cell fusion, Virology, 350, 323, 10.1016/j.virol.2006.01.033

Stantchev, 2007, The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages, Virus Res., 123, 178, 10.1016/j.virusres.2006.09.004

Harmon, 2008, Induction of the Gαq signaling cascade by the human immunodeficiency virus envelope is required for virus entry, J. Virol., 82, 9191, 10.1128/JVI.00424-08

Harmon, 2010, Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step, PLoS Pathog., 6, e1000956, 10.1371/journal.ppat.1000956

Miyauchi, 2009, HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes, Cell, 137, 433, 10.1016/j.cell.2009.02.046

Ichihashi, 1971, Biogenesis of poxviruses: Interrelationship between hemagglutinin production and polykaryocytosis, Virology, 46, 533, 10.1016/0042-6822(71)90057-2

Turner, 1992, An orthopoxvirus serpin-like gene controls the ability of infected cells to fuse, J. Virol., 66, 2076, 10.1128/jvi.66.4.2076-2085.1992

Law, 1992, A vaccinia serine protease inhibitor which prevents virus-induced cell fusion, J. Gen. Virol., 73, 549, 10.1099/0022-1317-73-3-549

Zhou, 1992, The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion, Virology, 189, 678, 10.1016/0042-6822(92)90591-C

Wagenaar, 2007, Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex, J. Virol., 81, 6286, 10.1128/JVI.00274-07

Turner, 2006, The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells, Virology, 347, 88, 10.1016/j.virol.2005.11.012

Wagenaar, 2009, Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion, J. Virol., 83, 1546, 10.1128/JVI.01684-08

Gong, 1990, Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein, Virology, 178, 81, 10.1016/0042-6822(90)90381-Z

Blasco, 1991, Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000 dalton outer envelope protein, J. Virol., 65, 5910, 10.1128/jvi.65.11.5910-5920.1991

Vanderplasschen, 1998, Intracellular and extracellular vaccinia virions enter cells by different mechanisms, J. Gen. Virol., 79, 877, 10.1099/0022-1317-79-4-877

Chang, 2012, Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH, J. Virol., 86, 3809, 10.1128/JVI.06081-11

Joklik, 1964, The intracellular uncoating of poxvirus DNA. I. The fate of radioactively-labeled rabbitpox virus, J. Mol. Biol., 8, 263, 10.1016/S0022-2836(64)80136-4

Moss, 1971, Assembly of virus particles during mixed infection with wild-type vaccinia and a refampicin-resistant mutant, Virology, 45, 135, 10.1016/0042-6822(71)90120-6

Christen, 1990, Superinfection exclusion of vaccinia virus in virus-infected cell cultures, Virology, 174, 35, 10.1016/0042-6822(90)90051-R

Turner, 2008, The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus, Virology, 380, 226, 10.1016/j.virol.2008.07.020

Doceul, 2010, Repulsion of superinfecting virions: A mechanism for rapid virus spread, Science, 327, 873, 10.1126/science.1183173

Schmidt, 2012, Poxvirus host cell entry, Curr. Opin. Virol., 2, 20, 10.1016/j.coviro.2011.11.007